Zylox-Tonbridge Medical Technology Co., Ltd. (HKG:2190)
Hong Kong · Delayed Price · Currency is HKD 21.04
+1.34 (6.80%)
Aug 21, 2026, 4:08 PM HKT
HKG:2190 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 579.71 | 579.56 | 418.11 | 1,087 | 1,205 | 1,418 |
Short-Term Investments | 787.64 | 1,132 | 804.24 | 355.55 | 545.14 | 1,500 |
Trading Asset Securities | 115.58 | 20.09 | 60.54 | 68.74 | 110.23 | 10.52 |
Cash & Short-Term Investments | 1,483 | 1,732 | 1,283 | 1,511 | 1,861 | 2,929 |
Cash Growth | -8.18% | 35.00% | -15.09% | -18.80% | -36.47% | 823.19% |
Accounts Receivable | 35.58 | 8.33 | 1.54 | 1.18 | 1.01 | 0.45 |
Other Receivables | - | 13.08 | 14.54 | 12.76 | 11.42 | 5.07 |
Receivables | 35.58 | 21.41 | 16.08 | 13.94 | 12.43 | 5.52 |
Inventory | 238.78 | 185.78 | 223.74 | 183.68 | 163.05 | 80.91 |
Restricted Cash | - | - | - | - | 0.65 | - |
Other Current Assets | 72.97 | 7.72 | 6.33 | 8.7 | 25.8 | 8.91 |
Total Current Assets | 1,830 | 1,947 | 1,529 | 1,717 | 2,063 | 3,024 |
Property, Plant & Equipment | 746.84 | 702.49 | 665.5 | 578.36 | 338.38 | 212.39 |
Long-Term Investments | 906.01 | 868.36 | 1,227 | 1,066 | 832.44 | - |
Other Intangible Assets | 229.94 | 40.74 | 28.01 | 9.69 | 9.64 | 4.89 |
Long-Term Deferred Tax Assets | 1.53 | 7.63 | - | - | - | - |
Other Long-Term Assets | 18.71 | 7.64 | 3.31 | 4.28 | 10.65 | 6.8 |
Total Assets | 3,733 | 3,574 | 3,453 | 3,376 | 3,254 | 3,248 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 245.29 | 76.49 | 69.37 | 42.44 | 18.26 | 21.58 |
Accrued Expenses | - | 93.12 | 72.06 | 70.74 | 70.16 | 39.86 |
Short-Term Debt | 86.77 | 60 | 87 | 50 | - | - |
Current Portion of Leases | 9.69 | 2.29 | 2.4 | 4.02 | 6.54 | 2.9 |
Current Unearned Revenue | 32.4 | 24.26 | 16.86 | 19.92 | 9.6 | 3.42 |
Other Current Liabilities | 17.99 | 69.59 | 86.47 | 130.66 | 47.53 | 29.35 |
Total Current Liabilities | 392.13 | 325.74 | 334.17 | 317.78 | 152.08 | 97.1 |
Long-Term Debt | 292.3 | - | - | - | - | - |
Long-Term Leases | 22.09 | 1.35 | 1.5 | 1.86 | 7.46 | 6.51 |
Long-Term Unearned Revenue | 16.57 | 16.75 | 15.89 | 8.67 | - | - |
Total Liabilities | 734.02 | 343.83 | 351.56 | 328.32 | 159.54 | 103.61 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 344.13 | 344.13 | 330.18 | 332.4 | 332.4 | 332.4 |
Additional Paid-In Capital | 2,180 | 2,149 | 2,091 | 2,270 | 2,270 | 2,270 |
Retained Earnings | 350.98 | 298.89 | 87.2 | -481.91 | -403.17 | -289.62 |
Treasury Stock | -294.4 | -182.46 | -100.7 | -87.59 | -33.79 | -9.15 |
Comprehensive Income & Other | 395.04 | 619.83 | 693.79 | 1,014 | 928.69 | 841.01 |
Shareholders' Equity | 2,999 | 3,230 | 3,101 | 3,047 | 3,094 | 3,145 |
Total Liabilities & Equity | 3,733 | 3,574 | 3,453 | 3,376 | 3,254 | 3,248 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 410.85 | 63.64 | 90.91 | 55.88 | 14 | 9.41 |
Net Cash (Debt) | 1,072 | 1,668 | 1,192 | 1,455 | 1,847 | 2,919 |
Net Cash Growth | -30.01% | 39.95% | -18.08% | -21.21% | -36.75% | 931.49% |
Net Cash Per Share | 3.36 | 5.16 | 3.63 | 4.43 | 5.59 | 9.91 |
Filing Date Shares Outstanding | 318.79 | 337.29 | 319.8 | 324.05 | 329.69 | 331.92 |
Total Common Shares Outstanding | 318.79 | 337.29 | 319.8 | 324.05 | 329.69 | 331.92 |
Working Capital | 1,438 | 1,621 | 1,195 | 1,399 | 1,911 | 2,927 |
Book Value Per Share | 9.33 | 9.58 | 9.70 | 9.40 | 9.39 | 9.47 |
Tangible Book Value | 2,746 | 3,189 | 3,073 | 3,038 | 3,085 | 3,140 |
Tangible Book Value Per Share | 8.61 | 9.46 | 9.61 | 9.37 | 9.36 | 9.46 |
Buildings | - | 629.83 | 160.21 | 160.12 | 156.14 | 139.25 |
Machinery | - | 116.44 | 100.81 | 412.37 | 75.65 | 43.25 |
Construction In Progress | - | 15.55 | 431.29 | - | 77.99 | 5.85 |
Leasehold Improvements | - | 33.43 | 32.65 | 32.24 | 21.7 | 13.97 |